<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33956876</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>5</Issue><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Fat mass loss correlates with faster disease progression in amyotrophic lateral sclerosis patients: Exploring the utility of dual-energy x-ray absorptiometry in a prospective study.</ArticleTitle><Pagination><StartPage>e0251087</StartPage><MedlinePgn>e0251087</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0251087</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0251087</ELocationID><Abstract><AbstractText Label="BACKGROUND/OBJECTIVE">Weight loss is a predictor of shorter survival in amyotrophic lateral sclerosis (ALS). We performed serial measures of body composition using Dual-energy X-ray Absorptiometry (DEXA) in ALS patients to explore its utility as a biomarker of disease progression.</AbstractText><AbstractText Label="METHODS">DEXA data were obtained from participants with ALS (enrollment, at 6- and 12- months follow ups) and Parkinson's disease (enrollment and at 4-month follow up) as a comparator group. Body mass index, total lean mass index, appendicular lean mass index, total fat mass index, and percentage body fat at enrollment were compared between the ALS and PD cohorts and age-matched normative data obtained from the National Health and Nutrition Examination Survey database. Estimated monthly changes of body composition measures in the ALS cohort were compared to those of the PD cohort and were correlated with disease progression measured by the Revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R).</AbstractText><AbstractText Label="RESULTS">The ALS cohort (N = 20) had lower baseline total and appendicular lean mass indices compared to the PD cohort (N = 20) and general population. Loss in total and appendicular lean masses were found to be significantly associated with follow-up time. Low baseline percentage body fat (r = 0.72, p = 0.04), loss of percentage body fat (r = 0.81, p = 0.01), and total fat mass index (r = 0.73, p = 0.04) during follow up correlated significantly with monthly decline of ALSFRS-R scores in ALS cohort who had 2 or more follow-ups (N = 8).</AbstractText><AbstractText Label="CONCLUSION">Measurement of body composition with DEXA might serve as a biomarker for rapid disease progression in ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Ikjae</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-0537-9622</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kazamel</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McPherson</LastName><ForeName>Tarrant</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McAdam</LastName><ForeName>Jeremy</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cell, Developmental, &amp; Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bamman</LastName><ForeName>Marcas</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cell, Developmental, &amp; Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Birmingham Veterans Affairs Medical Center, Birmingham, Alabama, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amara</LastName><ForeName>Amy</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Daniel L</ForeName><Initials>DL</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>King</LastName><ForeName>Peter H</ForeName><Initials>PH</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cell, Developmental, &amp; Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Birmingham Veterans Affairs Medical Center, Birmingham, Alabama, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R21 NS111275</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS092651</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>I01 BX004419</GrantID><Acronym>BX</Acronym><Agency>BLRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 DK056336</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>I01 BX001148</GrantID><Acronym>BX</Acronym><Agency>BLRD VA</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015502" MajorTopicYN="N">Absorptiometry, Photon</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000273" MajorTopicYN="N">Adipose Tissue</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>6</Day><Hour>18</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33956876</ArticleId><ArticleId IdType="pmc">PMC8101939</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0251087</ArticleId><ArticleId IdType="pii">PONE-D-20-36763</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Desport JC, Preux PM, Truong TC, Vallat JM, Sautereau D, Couratier P. Nutritional status is a prognostic factor for survival in ALS patients. Neurology. 1999;53(5):1059&#x2013;63. 10.1212/wnl.53.5.1059</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.53.5.1059</ArticleId><ArticleId IdType="pubmed">10496266</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin B, Desport JC, Kajeu P, Jesus P, Nicolaud B, Nicol M, et al.. Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients. J Neurol Neurosurg Psychiatry. 2011;82(6):628&#x2013;34. 10.1136/jnnp.2010.211474</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.211474</ArticleId><ArticleId IdType="pubmed">21097551</ArticleId></ArticleIdList></Reference><Reference><Citation>Moglia C, Calvo A, Grassano M, Canosa A, Manera U, D&#x2019;Ovidio F, et al.. Early weight loss in amyotrophic lateral sclerosis: outcome relevance and clinical correlates in a population-based cohort. J Neurol Neurosurg Psychiatry. 2019;90(6):666&#x2013;73. 10.1136/jnnp-2018-319611</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-319611</ArticleId><ArticleId IdType="pubmed">30630957</ArticleId></ArticleIdList></Reference><Reference><Citation>Spataro R, Ficano L, Piccoli F, La Bella V. Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: effect on survival. J Neurol Sci. 2011;304(1&#x2013;2):44&#x2013;8. 10.1016/j.jns.2011.02.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2011.02.016</ArticleId><ArticleId IdType="pubmed">21371720</ArticleId></ArticleIdList></Reference><Reference><Citation>Wills AM, Hubbard J, Macklin EA, Glass J, Tandan R, Simpson EP, et al.. Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet. 2014;383(9934):2065&#x2013;72. 10.1016/S0140-6736(14)60222-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)60222-1</ArticleId><ArticleId IdType="pmc">PMC4176708</ArticleId><ArticleId IdType="pubmed">24582471</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph AC, Dorst J, Dreyhaupt J, Weishaupt JH, Kassubek J, Weiland U, et al.. Effect of High-Caloric Nutrition on Survival in Amyotrophic Lateral Sclerosis. Ann Neurol. 2020;87(2):206&#x2013;16. 10.1002/ana.25661</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25661</ArticleId><ArticleId IdType="pubmed">31849093</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Oudart H, Rene F, Gonzalez de Aguilar JL, Loeffler JP. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci U S A. 2004;101(30):11159&#x2013;64. 10.1073/pnas.0402026101</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0402026101</ArticleId><ArticleId IdType="pmc">PMC503756</ArticleId><ArticleId IdType="pubmed">15263088</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannides ZA, Ngo ST, Henderson RD, McCombe PA, Steyn FJ. Altered Metabolic Homeostasis in Amyotrophic Lateral Sclerosis: Mechanisms of Energy Imbalance and Contribution to Disease Progression. Neurodegener Dis. 2016;16(5&#x2013;6):382&#x2013;97. 10.1159/000446502</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000446502</ArticleId><ArticleId IdType="pubmed">27400276</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandoorne T, De Bock K, Van Den Bosch L. Energy metabolism in ALS: an underappreciated opportunity? Acta Neuropathol. 2018;135(4):489&#x2013;509. 10.1007/s00401-018-1835-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1835-x</ArticleId><ArticleId IdType="pmc">PMC5978930</ArticleId><ArticleId IdType="pubmed">29549424</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Pradat PF, Ludolph AC, Loeffler JP. Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol. 2011;10(1):75&#x2013;82. 10.1016/S1474-4422(10)70224-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70224-6</ArticleId><ArticleId IdType="pubmed">21035400</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngo ST, van Eijk RPA, Chachay V, van den Berg LH, McCombe PA, Henderson RD, et al.. Loss of appetite is associated with a loss of weight and fat mass in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20(7&#x2013;8):497&#x2013;505. 10.1080/21678421.2019.1621346</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1621346</ArticleId><ArticleId IdType="pubmed">31144522</ArticleId></ArticleIdList></Reference><Reference><Citation>Shepherd JA, Ng BK, Sommer MJ, Heymsfield SB. Body composition by DXA. Bone. 2017;104:101&#x2013;5. 10.1016/j.bone.2017.06.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bone.2017.06.010</ArticleId><ArticleId IdType="pmc">PMC5659281</ArticleId><ArticleId IdType="pubmed">28625918</ArticleId></ArticleIdList></Reference><Reference><Citation>Nau KL, Bromberg MB, Forshew DA, Katch VL. Individuals with amyotrophic lateral sclerosis are in caloric balance despite losses in mass. J Neurol Sci. 1995;129 Suppl:47&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">7595619</ArticleId></ArticleIdList></Reference><Reference><Citation>Amara AW, Wood KH, Joop A, Memon RA, Pilkington J, Tuggle SC, et al.. Randomized, Controlled Trial of Exercise on Objective and Subjective Sleep in Parkinson&#x2019;s Disease. Mov Disord. 2020. 10.1002/mds.28009</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28009</ArticleId><ArticleId IdType="pubmed">32092190</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan B, Shepherd JA, Levine MA, Steinberg D, Wacker W, Barden HS, et al.. National Health and Nutrition Examination Survey whole-body dual-energy X-ray absorptiometry reference data for GE Lunar systems. J Clin Densitom. 2014;17(3):344&#x2013;77. 10.1016/j.jocd.2013.08.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocd.2013.08.019</ArticleId><ArticleId IdType="pubmed">24161789</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenward MG, Roger JH. Small sample inference for fixed effects from restricted maximum likelihood. Biometrics. 1997;53(3):983&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">9333350</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, et al.. Movement Disorder Society-sponsored revision of the Unified Parkinson&#x2019;s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23(15):2129&#x2013;70. 10.1002/mds.22340</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.22340</ArticleId><ArticleId IdType="pubmed">19025984</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasarskis EJ, Berryman S, Vanderleest JG, Schneider AR, McClain CJ. Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death. Am J Clin Nutr. 1996;63(1):130&#x2013;7. 10.1093/ajcn/63.1.130</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/63.1.130</ArticleId><ArticleId IdType="pubmed">8604660</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallo V, Wark PA, Jenab M, Pearce N, Brayne C, Vermeulen R, et al.. Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis: the EPIC cohort. Neurology. 2013;80(9):829&#x2013;38. 10.1212/WNL.0b013e3182840689</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182840689</ArticleId><ArticleId IdType="pmc">PMC3598455</ArticleId><ArticleId IdType="pubmed">23390184</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariosa D, Beard JD, Umbach DM, Bellocco R, Keller J, Peters TL, et al.. Body Mass Index and Amyotrophic Lateral Sclerosis: A Study of US Military Veterans. Am J Epidemiol. 2017;185(5):362&#x2013;71. 10.1093/aje/kww140</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kww140</ArticleId><ArticleId IdType="pmc">PMC5860019</ArticleId><ArticleId IdType="pubmed">28158443</ArticleId></ArticleIdList></Reference><Reference><Citation>Aberg M, Nyberg J, Robertson J, Kuhn G, Schioler L, Nissbrandt H, et al.. Risk factors in Swedish young men for amyotrophic lateral sclerosis in adulthood. J Neurol. 2018;265(3):460&#x2013;70. 10.1007/s00415-017-8719-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-017-8719-1</ArticleId><ArticleId IdType="pmc">PMC5834569</ArticleId><ArticleId IdType="pubmed">29285652</ArticleId></ArticleIdList></Reference><Reference><Citation>Doyle P, Brown A, Beral V, Reeves G, Green J. Incidence of and risk factors for motor neurone disease in UK women: a prospective study. BMC Neurol. 2012;12:25. 10.1186/1471-2377-12-25</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-12-25</ArticleId><ArticleId IdType="pmc">PMC3512483</ArticleId><ArticleId IdType="pubmed">22559076</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Reilly EJ, Wang M, Adami HO, Alonso A, Bernstein L, van den Brandt P, et al.. Prediagnostic body size and risk of amyotrophic lateral sclerosis death in 10 studies. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19(5&#x2013;6):396&#x2013;406. 10.1080/21678421.2018.1452944</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1452944</ArticleId><ArticleId IdType="pmc">PMC6423444</ArticleId><ArticleId IdType="pubmed">29658324</ArticleId></ArticleIdList></Reference><Reference><Citation>Peter RS, Rosenbohm A, Dupuis L, Brehme T, Kassubek J, Rothenbacher D, et al.. Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis: results from the ALS registry Swabia. Eur J Epidemiol. 2017;32(10):901&#x2013;8. 10.1007/s10654-017-0318-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-017-0318-z</ArticleId><ArticleId IdType="pubmed">28975435</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakken O, Meyer HE, Stigum H, Holmoy T. High BMI is associated with low ALS risk: A population-based study. Neurology. 2019;93(5):e424&#x2013;e32. 10.1212/WNL.0000000000007861</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000007861</ArticleId><ArticleId IdType="pubmed">31243073</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, et al.. Prognostic factors in ALS: A critical review. Amyotroph Lateral Scler. 2009;10(5&#x2013;6):310&#x2013;23. 10.3109/17482960802566824</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960802566824</ArticleId><ArticleId IdType="pmc">PMC3515205</ArticleId><ArticleId IdType="pubmed">19922118</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly TL, Wilson KE, Heymsfield SB. Dual energy X-Ray absorptiometry body composition reference values from NHANES. PLoS One. 2009;4(9):e7038. 10.1371/journal.pone.0007038</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0007038</ArticleId><ArticleId IdType="pmc">PMC2737140</ArticleId><ArticleId IdType="pubmed">19753111</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans WJ, Hellerstein M, Orwoll E, Cummings S, Cawthon PM. D3 -Creatine dilution and the importance of accuracy in the assessment of skeletal muscle mass. J Cachexia Sarcopenia Muscle. 2019;10(1):14&#x2013;21. 10.1002/jcsm.12390</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcsm.12390</ArticleId><ArticleId IdType="pmc">PMC6438329</ArticleId><ArticleId IdType="pubmed">30900400</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannides ZA, Steyn FJ, Henderson RD, McCombe PA, Ngo ST. Anthropometric measures are not accurate predictors of fat mass in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(7&#x2013;8):486&#x2013;91. 10.1080/21678421.2017.1317811</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1317811</ArticleId><ArticleId IdType="pubmed">28446030</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowry DW, Tomiyama AJ. Air displacement plethysmography versus dual-energy x-ray absorptiometry in underweight, normal-weight, and overweight/obese individuals. PLoS One. 2015;10(1):e0115086. 10.1371/journal.pone.0115086</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0115086</ArticleId><ArticleId IdType="pmc">PMC4301864</ArticleId><ArticleId IdType="pubmed">25607661</ArticleId></ArticleIdList></Reference><Reference><Citation>Nau KL, Dick AR, Peters K, Schloerb PR. Relative validity of clinical techniques for measuring the body composition of persons with amyotrophic lateral sclerosis. J Neurol Sci. 1997;152 Suppl 1:S36&#x2013;42. 10.1016/s0022-510x(97)00242-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-510x(97)00242-6</ArticleId><ArticleId IdType="pubmed">9419052</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong VW, Tan YJ, Ng YD, Choo XY, Sugumaran K, Chinna K, et al.. Progressive and accelerated weight and body fat loss in Parkinson&#x2019;s disease: A three-year prospective longitudinal study. Parkinsonism Relat Disord. 2020;77:28&#x2013;35. 10.1016/j.parkreldis.2020.06.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2020.06.015</ArticleId><ArticleId IdType="pubmed">32615497</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazamel M, Cutter G, Claussen G, Alsharabati M, Oh SJ, Lu L, et al.. Epidemiological features of amyotrophic lateral sclerosis in a large clinic-based African American population. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(5&#x2013;6):334&#x2013;7. 10.3109/21678421.2013.770030</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.770030</ArticleId><ArticleId IdType="pmc">PMC3732496</ArticleId><ArticleId IdType="pubmed">23458155</ArticleId></ArticleIdList></Reference><Reference><Citation>Punjani R, Wagner L, Horton K, Kaye W. Atlanta metropolitan area amyotrophic lateral sclerosis (ALS) surveillance: incidence and prevalence 2009&#x2013;2011 and survival characteristics through 2015. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21(1&#x2013;2):123&#x2013;30. 10.1080/21678421.2019.1682614</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1682614</ArticleId><ArticleId IdType="pubmed">31795746</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>